Cargando…

Metabolic acidosis of chronic kidney disease and subclinical cardiovascular disease markers: Friend or foe?

The effect of chronic metabolic acidosis (MA) on cardiovascular disease (CVD) in the setting of chronic kidney disease (CKD) is largely unknown. Therefore, we aimed to study this relationship in nondialysis CKD patients. This cross-sectional, single-center study prospectively enrolled 95 clinically...

Descripción completa

Detalles Bibliográficos
Autores principales:	Căpuşă, Cristina, Ştefan, Gabriel, Stancu, Simona, Lipan, Mariana, Tsur, Lilach Daniel, Mircescu, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5200
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708981/ https://www.ncbi.nlm.nih.gov/pubmed/29381982 http://dx.doi.org/10.1097/MD.0000000000008802

Ejemplares similares

Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients
por: Căpuşa, Cristina, et al.
Publicado: (2016)

Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
por: Hildegard Stancu, Simona, et al.
Publicado: (2018)

Circulating TNF receptors predict cardiovascular disease in patients with chronic kidney disease
por: Bae, Eunjin, et al.
Publicado: (2017)

Sarcopenia predicts cardiovascular disease in chronic kidney disease at advanced stage and associated risks
por: Xuan, Yingli, et al.
Publicado: (2023)

Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease
por: Lai, Silvia, et al.
Publicado: (2016)

The Incidence of Cardiovascular Events Is Comparable Between Normoalbuminuric and Albuminuric Diabetic Patients With Chronic Kidney Disease
por: Lee, Eunyoung, et al.
Publicado: (2016)

Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients
por: Sans, Laia, et al.
Publicado: (2016)

Thyroid dysfunction and cardiovascular events in patients with chronic kidney disease: A protocol of systematic review and meta-analysis
por: Liu, Tongtong, et al.
Publicado: (2020)

Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis
por: Liu, Hongyan, et al.
Publicado: (2021)

Primary prevention of cardiovascular disease events with renin-angiotensin system blockade in autosomal dominant polycystic kidney disease dialysis patients: A nationwide cohort study
por: Lu, Chien-Lin, et al.
Publicado: (2021)

Prevalence of Metformin Use and the Associated Risk of Metabolic Acidosis in US Diabetic Adults With CKD: A National Cross-Sectional Study
por: Kuo, Chin-Chi, et al.
Publicado: (2015)

Primary Sjögren syndrome-associated acute interstitial nephritis and type 3 renal tubular acidosis in a patient with thin basement membrane nephropathy: A case report
por: Du, Tian, et al.
Publicado: (2020)

Renal diseases associated with multiple sclerosis: A narrative review
por: Alugba, Gabriel, et al.
Publicado: (2022)

Prevalence, clinical profile, and risk factors of peripheral artery disease in an Iraqi cohort of chronic kidney disease
por: Sinjari, Hussein Yousif
Publicado: (2023)

Risk factors for heart valve calcification in chronic kidney disease
por: Rong, Shu, et al.
Publicado: (2018)

Malignancy diseases and kidneys: A nephrologist prospect and updated review
por: Habas, Elmukhtar, et al.
Publicado: (2023)

Comprehensive review of current management guidelines of chronic kidney disease
por: Elendu, Chukwuka, et al.
Publicado: (2023)

Plasma Uromodulin Correlates With Kidney Function and Identifies Early Stages in Chronic Kidney Disease Patients
por: Steubl, Dominik, et al.
Publicado: (2016)

The relationships of sleep apnea, hypertension, and resistant hypertension on chronic kidney disease
por: Chang, Chih-Ping, et al.
Publicado: (2016)

Alteration of brain connectivity in neurologically asymptomatic patients with chronic kidney disease
por: Lee, Yoo Jin, et al.
Publicado: (2021)

S-glutathionylation, friend or foe in cardiovascular health and disease
por: Rashdan, N.A., et al.
Publicado: (2020)

Risk factors of gender for renal progression in patients with early chronic kidney disease
por: Chang, Po-Ya, et al.
Publicado: (2016)

Efficacy and safety of pemafibrate in patients with chronic kidney disease: A retrospective study
por: Iwasaki, Masako, et al.
Publicado: (2023)

Clinical characteristics and risk factors for kidney failure in patients with autosomal dominant polycystic kidney disease: A retrospective study
por: Park, Hanil, et al.
Publicado: (2022)

The Power of Renal Function Estimation Equations for Predicting Long-Term Kidney Graft Survival: A Retrospective Comparison of the Chronic Kidney Disease Epidemiology Collaboration and the Modification of Diet in Renal Disease Study Equations
por: Choi, Hoon Young, et al.
Publicado: (2016)

The Pivotal Role of a Novel Biomarker of Reactive Oxygen Species in Chronic Kidney Disease
por: Hirata, Yoshihiro, et al.
Publicado: (2015)

Evidence for Chronic Kidney Disease-Mineral and Bone Disorder Associated With Metabolic Pathway Changes
por: Wu, Qiong, et al.
Publicado: (2015)

Peritoneal Dialysis is Associated With A Better Survival in Cirrhotic Patients With Chronic Kidney Disease
por: Chou, Che-Yi, et al.
Publicado: (2016)

Neurological, psychological, and cognitive disorders in patients with chronic kidney disease on conservative and replacement therapy
por: Lai, Silvia, et al.
Publicado: (2016)

Autosomal dominant polycystic kidney disease combined with hypertrophic cardiomyopathy: A case report
por: Shen, Yingjing, et al.
Publicado: (2017)

Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease
por: Sahutoglu, Tuncay, et al.
Publicado: (2017)

Higher volume of water intake is associated with lower risk of albuminuria and chronic kidney disease
por: Wang, Hung-Wei, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on patients with chronic kidney disease: A narrative review
por: Huang, Wanbing, et al.
Publicado: (2022)

Management of diabetic kidney disease: where do we stand?: A narrative review
por: Sindhu, Devada, et al.
Publicado: (2023)

Mini review: A reevaluation of nutritional vitamin D in the treatment of chronic kidney disease
por: Shen, Yingjing
Publicado: (2023)

FN1 and TGFBI are key biomarkers of macrophage immune injury in diabetic kidney disease
por: Dou, Fulin, et al.
Publicado: (2023)

Management of hypertensive crisis in a patient with underlying kidney disease: A case report
por: Elendu, Chukwuka, et al.
Publicado: (2023)

Risk Factors for Long-Term Mortality and Progressive Chronic Kidney Disease Associated With Acute Kidney Injury After Cardiac Surgery
por: Xu, Jia-Rui, et al.
Publicado: (2015)

Glycated Albumin is Independently Associated With Arterial Stiffness in Non-Diabetic Chronic Kidney Disease Patients
por: Choi, Hoon Young, et al.
Publicado: (2016)

Retinal Vessel Diameter and Chronic Kidney Disease in Rural China: A Cross-Sectional Study
por: Bao, Shumin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_28clp0pjtlqg71c7fd1snpfjp0